April 1, 2020 Price forecast | 2 weeks: 5.33% | 1 month: 4.55% | 3 months: 11.24% | Premium Forecast


SPPI stock forecast

Our latest prediction for Spectrum Pharmaceuticals, Inc.'s stock price was made on the April 1, 2020 when the stock price was at 2.11$.

In the short term (2weeks), SPPI's stock price should outperform the market by 5.33%. During that period the price should oscillate between -10.93% and +21.29%.

In the medium term (3months), SPPI's stock price should outperform the market by 11.24%. During that period the price should oscillate between -26.17% and +58.68%.

Create a solid portfolio with SPPI

Add SPPI to your portfolio and optimize it!


About Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.

At the moment the company generates 109M USD in revenues.

On its last earning announcement, the company reported a loss of -1.20$ per share.

The book value per share is 3.25$

Spectrum Pharmaceuticals, Inc. website


Three months stock forecastApril 1, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
109M 75.50% -134M -120.00% -134M -1.20 - - 111M 3.25 -128M -10M -138M